William Garrow Kerr

USPTO Granted Patents = 16 (Patent Applications = 8)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 20(Granted Patents)

Location History:

Tampa, FL (US) (2010)
Syracuse, NY (US) (2011 - 2024)

Company Filing History:

9 out of 1,935

University of South Florida

patents

6 out of 1,996

The State University of New York

patents

1 out of 290

H. Lee Moffitt Cancer Center and Research Institute, Inc.

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11952328 - Selective ship inhibitors for treating disease (2024-04-09),

2. 11319336 - Ship inhibitors and uses thereof (2022-05-03),

3. 10890579 - Methods and kits for detecting a fusion messenger RNA transcript or a polypeptide encoded by the fusion messenger RNA transcript (2021-01-12),

4. 10736877 - Tryptamine-based ship inhibitors for the treatment of cancer (2020-08-11),

5. 10702538 - Ship inhibition to induce activation of natural killer cells (2020-07-07),

6. 9447139 - Ship inhibitors and uses thereof (2016-09-20),

7. 9006221 - Method of modulating ship activity (2015-04-14),

8. 8440395 - Methods of detecting and treating colon disorders (2013-05-14),

9. 8399510 - Method of activating NK cells (2013-03-19),

10. 8163710 - Reduction of graft-versus-host disease by modulation of SHIP activity (2012-04-24),

11. 8008273 - SHIP-deficiency to increase megakaryocyte progenitor production (2011-08-30),

12. 7807646 - SHIP-deficiency to increase megakaryocyte progenitor production (2010-10-05),

13. 7763592 - SHIP-deficiency to increase megakaryocyte progenitor production (2010-07-27),

14. 7713945 - Control of NK cell function and survival by modulation of SHIP activity (2010-05-11),

15. 7704963 - [object Object] (2010-04-27),

Title: William Garrow Kerr: An Innovative Mind in Medical Research

Introduction

William Garrow Kerr, an accomplished inventor based in Syracuse, NY, has made significant contributions to the medical field with a total of 16 patents to his name. His innovative work primarily focuses on developing selective ship inhibitors that have the potential to treat various medical conditions. Through his research, Kerr has shown a commitment to finding solutions to complex health issues that affect numerous individuals.

Latest Patents

Among Kerr's latest patents are compositions that inhibit the SH2-containing inositol 5′ phosphatase (SHIP). These compositions aim to ameliorate the effects of various medical conditions in subjects. The inventions include methods for treating graft-versus-host disease, inhibiting tumor growth, and treating multiple myeloma and breast cancer. The detailed applications of his work underscore the possibilities of modulating SHIP activity in various medical contexts.

Career Highlights

Kerr has had a notable career, collaborating with prestigious institutions such as the University of South Florida and The Research Foundation for the State University of New York. His work in these environments has allowed him to contribute to advanced research and to push the boundaries of medical science.

Collaborations

Throughout his career, William Kerr has collaborated with notable individuals, including Caroline Desponts and John D Chisholm. These collaborations have enriched his research and contributed to the development of innovative medical solutions.

Conclusion

William Garrow Kerr exemplifies the spirit of innovation and dedication to medical research. His impressive portfolio of patents demonstrates a relentless pursuit of knowledge and an unwavering commitment to improving health outcomes for individuals facing serious medical challenges. Through his inventions, Kerr has not only advanced scientific understanding but also paved the way for potential treatments that could benefit countless lives.

This text is generated by artificial intelligence and may not be accurate.